tiprankstipranks
Trending News
More News >
Shandong Boan Biotechnology Company., Limited. Class H (HK:6955)
:6955
Hong Kong Market

Compare Shandong Boan Biotechnology Company., Limited. Class H (6955) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Shandong Boan Biotechnology Company., Limited. Class H
HK$8.33
HK$5.18B
134.79
-4.25%
Alphamab Oncology
HK$9.58
HK$8.68B
33.97
175.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$12.33
HK$13.69B
-48.42
240.74%
1 Buy
0 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.08
HK$10.51B
16.10
225.14%
1 Buy
0 Hold
0 Sell
Moderate Buy
Abbisko Cayman Limited
HK$13.02
HK$8.50B
44.66
159.34%
2 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$17.42B
121.79
457.56%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
8.33
-0.37
-4.25%
HK:9966
Alphamab Oncology
8.91
5.58
167.57%
HK:1672
Ascletis Pharma, Inc.
13.80
9.79
244.14%
HK:2142
HBM Holdings Ltd.
11.90
8.16
218.18%
HK:2256
Abbisko Cayman Limited
12.50
7.68
159.34%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
43.88
35.97
454.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts